• About
  • Blog
  • Podcast
  • Speaking
  • Events
  • Services
  • Contact

FatAlpha

Investing website that displays stock ideas, opinions and my strategies.

You are here: Home / Stock Ideas / Company Analysis / Cyprus Value Investor Event Idea: Graftech

Cyprus Value Investor Event Idea: Graftech

October 10, 2018 By Sophocles Sophocleous

We just got done with the annual Value Investor Conference in Cyprus.  You can see scenes from the event in this video.  The event which this year had a 40 person cap was fully booked and participants enjoyed 25 presentations over the 2 days, as well as numerous activities including a private beer tasting, tour of the museum and a magic show.   22 investment ideas were presented and I’d like to share with you my presentation.

The investment idea I presented was Graftech (EAF).  The firm produces graphite electrodes.  Graphite electrodes (GE) are essential for use in an electric arc furnace which is used to produce steel.  Steel is produced in either a blast furnace or an electric arc furnace.  The number of electric arc furnaces are growing in demand as they produce 75% less carbon dioxide versus a blast furnace.   There is no substitute for a graphite electrode and as it is less than 5% of steel production cost manufacturers are willing to pay a premium for quality, reliability, and consistency.  GE acted like any volatile commodity until recently where prices are currently surging.  This is because not only is there additional demand but also product supply has dropped by 20%, the industry has consolidated with 2 of the top producers merging, and there is an alternative use for a key input.

To produce GE, you need petroleum needle coke and there is no substitute for this input.  Petroleum needle coke is also used in lithium batteries in electric vehicles.  10% of current petroleum needle coke goes towards this use.  This demand is expected to increase 10-fold!  As a result, this key input is rising in price.  Graftech though is the ONLY vertically integrated GE producer globally.  Over 66% of its long-term needs are met internally, and so has a huge cost advantage.  Essentially, the cost of production using their own needle coke is less the market price of needle coke alone!  According to management, it will take at least 5 years to see changes in capacity and hence the company will likely earn more for longer than the market expects.  A 10x P/E implies 49% upside to while a 7% FCF/EV implies 60% upside and this does not factor in the higher spot prices that are expected to be realized for 1/3 of production in 2019.  An additional catalyst is a potential special dividend or buyback which could be announced this year.

My slides from the event are shown below.  If your browser shows an error, you may need to do a hard reload of your browser to clear caching. Browser hard reload keystrokes:  Windows: Ctrl + F5, Mac/Apple: Apple + R or Cmd + R, Linux: F5

 

2018-Sophocles-Sophocleous-Investment-Idea

 

Share this:

  • Tweet
  • Reddit
  • WhatsApp
  • Pocket
  • Email
  • Print

Like this:

Like Loading...

Filed Under: Blog, Company Analysis

Free Insights & Substack

Charlie Munger quotes

"Avoid working directly under somebody you don't admire and don't want to be like."

Events

Disclaimer

fatalpha.com is not operated by a broker, a dealer, a registered investment adviser, or a regulated entity. Under no circumstances does any information posted represent a recommendation to buy or sell a security. In no event shall fatalpha.com, Sophocles Sophocleous, FATALPHA LTD, or any affiliates or associates be liable to any member or guest for any damages of any kind arising out of the use of any content available on the website. Past performance is a poor indicator of future performance. All the information on this site and any related materials is not intended to be, nor does it constitute investment advice or recommendations. All materials and information you obtain here are exclusively for informational purposes and does not constitute an offer or solicitation to provide any investment services to investors based in the U.S. or elsewhere.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Recent Posts

  • San Juan Royalty Trust with Brian Anast
  • 7+ Stock Ideas
  • ASSA with Pon Van Compernolle
  • ASML: The picks and shovels of chips
  • 1st FatAlpha Value (Asia)

Disclaimer

fatalpha.com is not operated by a broker, a dealer, a registered investment adviser, or a regulated entity. Under no circumstances does any information posted represent a recommendation to buy or sell a security. In no event shall fatalpha.com, Sophocles Sophocleous, FATALPHA LTD, or any affiliates or associates be liable to any member or guest for any damages of any kind arising out of the use of any content available on the website. Past performance is a poor indicator of future performance. All the information on this site and any related materials is not intended to be, nor does it constitute investment advice or recommendations. All materials and information you obtain here are exclusively for informational purposes and does not constitute an offer or solicitation to provide any investment services to investors based in the U.S. or elsewhere.

Search

Privacy Policy | Cookies Policy | Disclaimer |  Archive

Sophocles Sophocleous

A Fulbright scholar and Chartered Financial Analyst, has been active in the global financial markets since 1999. This website displays his personal thoughts and views. Read More…

Copyright © 2025 · FatAlpha · All rights reserved

*** Free Insights ***
Free stock ideas
Videos of idea discussions
Free substack included Unsubscribe any time
By subscribing, you give us permission to send you our monthly letter. We will NOT be in contact with you in any other way. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at info@fatalpha.com. We will treat your information with respect. For more information about our privacy practices please visit our website. By providing your email and subscribing, you agree that we may process your information in accordance with these terms. We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.
%d